Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026)

Zymeworks (ZYME) posted Other Non-Current Liabilities of $278000.0 for Q1 2026, little changed sequentially from $278000.0 in Q4 2025, and down 67.52% YoY from $856000.0 in Q1 2025.

Analysis

Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Zymeworks has reported Other Non-Current Liabilities for 6 years, with the latest figure at $278000.0 in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 67.52% year-over-year to $278000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $278000.0 (down 67.52% YoY) and the FY2025 annual result came in at $278000.0, down 69.88% from the prior year.
  • Other Non-Current Liabilities held at $278000.0 in Q1 2026 per ZYME's latest filing, from $278000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $3.6 million in Q2 2023 and troughed at $278000.0 in Q3 2025.
  • A 5-year average of $1.4 million and a median of $929000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities sank 90.01% in 2023, then jumped 217.06% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $1.6 million in 2022, then rose by 3.59% to $1.7 million in 2023, then plunged by 45.74% to $923000.0 in 2024, then sank by 69.88% to $278000.0 in 2025, then changed by 0.0% to $278000.0 in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $278000.0, $278000.0, and $278000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 278,000.00
Mar 31, 2026 278,000.00
Dec 31, 2025 278,000.00
Sep 30, 2025 278,000.00
Jun 30, 2025 828,000.00
Mar 31, 2025 856,000.00
Dec 31, 2024 923,000.00
Sep 30, 2024 929,000.00
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 1.70 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 3.60 Mn
Dec 31, 2022 3.10 Mn
Sep 30, 2022 2.93 Mn
Dec 31, 2021 7.75 Mn